Bharat Biotech's Covaxin cleared for conducting clinical trials on children above 12 years

The Drugs Controller General of India (DCGI) has given licensing permission to Hyderabad-based Bharat Biotech to manufacture 'Covaxin' for sale and distribution. The DCGI approval document said the firm can vaccinate children above the age of 12 years during the clinical trial mode. However, the DCGI has also asked the Bharat Biotech to submit updated safety, efficacy and immunogenicity data from the ongoing Phase I, II and Ill clinical trials till the completion of trials. 

from IndiaTV India: Google News Feed https://ift.tt/35a1qk2
via